ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Multiomics Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-12L17296
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Multiomics Market Research Report 2024
BUY CHAPTERS

Global Multiomics Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-12L17296
Report
November 2025
Pages:122
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
BD
Thermo Fisher Scientific Inc
Illumina Inc
Danaher (Beckman Coulter)
PerkinElmer Inc
Shimadzu Corporation
Bruker
Qiagen NV
Agilent Technologies Inc
BGI Genomics

Multiomics Market Size

The global Multiomics market is projected to grow from US$ 2835 million in 2024 to US$ 6124 million by 2031, at a CAGR of 11.8% (2025-2031), driven by critical product segments and diverse end‑use applications.

Multiomics Market

Multiomics Market

Multiomics is a new approach where the data sets of different omic groups are combined during analysis. The different omic strategies employed during multiomics are genome, proteome, transcriptome, epigenome, and microbiome.
Single cell multiomics technologies typically measure multiple types of molecules from the same individual cell, allowing for more in-depth biological insight than can be gained by analyzing each molecular layer from separate cells. Single-cell multimodal omics (scMulti-omics) technologies allow for the measurement of multiple modalities from the same cell, including DNA methylation, chromatin accessibility, RNA expression, protein abundance, gene perturbation, and spatial information, unlike live-cell fluorescence imaging, which involves the destruction of cells for analysis.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Multiomics market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Multiomics Market Report

Report Metric Details
Report Name Multiomics Market
Accounted market size in 2024 US$ 2835 in million
Forecasted market size in 2031 US$ 6124 million
CAGR 11.8%
Base Year 2024
Forecasted years 2025 - 2031
Segment by Type
  • Single-cell Multiomics
  • Bulk Multiomics
Segment by Application
  • Cell Biology
  • Oncology
  • Neurology
  • Immunology
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BD, Thermo Fisher Scientific, Inc., Illumina, Inc, Danaher (Beckman Coulter), PerkinElmer, Inc, Shimadzu Corporation, Bruker, QIAGEN, Agilent Technologies, Inc., BGI Genomics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Multiomics study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Multiomics Market growing?

Ans: The Multiomics Market witnessing a CAGR of 11.8% during the forecast period 2025-2031.

What is the Multiomics Market size in 2031?

Ans: The Multiomics Market size in 2031 will be US$ 6124 million.

Who are the main players in the Multiomics Market report?

Ans: The main players in the Multiomics Market are BD, Thermo Fisher Scientific, Inc., Illumina, Inc, Danaher (Beckman Coulter), PerkinElmer, Inc, Shimadzu Corporation, Bruker, QIAGEN, Agilent Technologies, Inc., BGI Genomics

What are the Application segmentation covered in the Multiomics Market report?

Ans: The Applications covered in the Multiomics Market report are Cell Biology, Oncology, Neurology, Immunology, Others

What are the Type segmentation covered in the Multiomics Market report?

Ans: The Types covered in the Multiomics Market report are Single-cell Multiomics, Bulk Multiomics

1 Study Coverage
1.1 Introduction to Multiomics: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Multiomics Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Single-cell Multiomics
1.2.3 Bulk Multiomics
1.3 Market Segmentation by Application
1.3.1 Global Multiomics Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Cell Biology
1.3.3 Oncology
1.3.4 Neurology
1.3.5 Immunology
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Multiomics Revenue Estimates and Forecasts 2020-2031
2.2 Global Multiomics Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Multiomics Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Multiomics Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Single-cell Multiomics Market Size by Players
3.3.2 Bulk Multiomics Market Size by Players
3.4 Global Multiomics Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Multiomics Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Multiomics Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Multiomics Market Size by Type (2020-2031)
6.4 North America Multiomics Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Multiomics Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Multiomics Market Size by Type (2020-2031)
7.4 Europe Multiomics Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Multiomics Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Multiomics Market Size by Type (2020-2031)
8.4 Asia-Pacific Multiomics Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Multiomics Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Multiomics Market Size by Type (2020-2031)
9.4 Central and South America Multiomics Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Multiomics Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Multiomics Market Size by Type (2020-2031)
10.4 Middle East and Africa Multiomics Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Multiomics Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 BD
11.1.1 BD Corporation Information
11.1.2 BD Business Overview
11.1.3 BD Multiomics Product Features and Attributes
11.1.4 BD Multiomics Revenue and Gross Margin (2020-2025)
11.1.5 BD Multiomics Revenue by Product in 2024
11.1.6 BD Multiomics Revenue by Application in 2024
11.1.7 BD Multiomics Revenue by Geographic Area in 2024
11.1.8 BD Multiomics SWOT Analysis
11.1.9 BD Recent Developments
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Thermo Fisher Scientific, Inc. Corporation Information
11.2.2 Thermo Fisher Scientific, Inc. Business Overview
11.2.3 Thermo Fisher Scientific, Inc. Multiomics Product Features and Attributes
11.2.4 Thermo Fisher Scientific, Inc. Multiomics Revenue and Gross Margin (2020-2025)
11.2.5 Thermo Fisher Scientific, Inc. Multiomics Revenue by Product in 2024
11.2.6 Thermo Fisher Scientific, Inc. Multiomics Revenue by Application in 2024
11.2.7 Thermo Fisher Scientific, Inc. Multiomics Revenue by Geographic Area in 2024
11.2.8 Thermo Fisher Scientific, Inc. Multiomics SWOT Analysis
11.2.9 Thermo Fisher Scientific, Inc. Recent Developments
11.3 Illumina, Inc
11.3.1 Illumina, Inc Corporation Information
11.3.2 Illumina, Inc Business Overview
11.3.3 Illumina, Inc Multiomics Product Features and Attributes
11.3.4 Illumina, Inc Multiomics Revenue and Gross Margin (2020-2025)
11.3.5 Illumina, Inc Multiomics Revenue by Product in 2024
11.3.6 Illumina, Inc Multiomics Revenue by Application in 2024
11.3.7 Illumina, Inc Multiomics Revenue by Geographic Area in 2024
11.3.8 Illumina, Inc Multiomics SWOT Analysis
11.3.9 Illumina, Inc Recent Developments
11.4 Danaher (Beckman Coulter)
11.4.1 Danaher (Beckman Coulter) Corporation Information
11.4.2 Danaher (Beckman Coulter) Business Overview
11.4.3 Danaher (Beckman Coulter) Multiomics Product Features and Attributes
11.4.4 Danaher (Beckman Coulter) Multiomics Revenue and Gross Margin (2020-2025)
11.4.5 Danaher (Beckman Coulter) Multiomics Revenue by Product in 2024
11.4.6 Danaher (Beckman Coulter) Multiomics Revenue by Application in 2024
11.4.7 Danaher (Beckman Coulter) Multiomics Revenue by Geographic Area in 2024
11.4.8 Danaher (Beckman Coulter) Multiomics SWOT Analysis
11.4.9 Danaher (Beckman Coulter) Recent Developments
11.5 PerkinElmer, Inc
11.5.1 PerkinElmer, Inc Corporation Information
11.5.2 PerkinElmer, Inc Business Overview
11.5.3 PerkinElmer, Inc Multiomics Product Features and Attributes
11.5.4 PerkinElmer, Inc Multiomics Revenue and Gross Margin (2020-2025)
11.5.5 PerkinElmer, Inc Multiomics Revenue by Product in 2024
11.5.6 PerkinElmer, Inc Multiomics Revenue by Application in 2024
11.5.7 PerkinElmer, Inc Multiomics Revenue by Geographic Area in 2024
11.5.8 PerkinElmer, Inc Multiomics SWOT Analysis
11.5.9 PerkinElmer, Inc Recent Developments
11.6 Shimadzu Corporation
11.6.1 Shimadzu Corporation Corporation Information
11.6.2 Shimadzu Corporation Business Overview
11.6.3 Shimadzu Corporation Multiomics Product Features and Attributes
11.6.4 Shimadzu Corporation Multiomics Revenue and Gross Margin (2020-2025)
11.6.5 Shimadzu Corporation Recent Developments
11.7 Bruker
11.7.1 Bruker Corporation Information
11.7.2 Bruker Business Overview
11.7.3 Bruker Multiomics Product Features and Attributes
11.7.4 Bruker Multiomics Revenue and Gross Margin (2020-2025)
11.7.5 Bruker Recent Developments
11.8 QIAGEN
11.8.1 QIAGEN Corporation Information
11.8.2 QIAGEN Business Overview
11.8.3 QIAGEN Multiomics Product Features and Attributes
11.8.4 QIAGEN Multiomics Revenue and Gross Margin (2020-2025)
11.8.5 QIAGEN Recent Developments
11.9 Agilent Technologies, Inc.
11.9.1 Agilent Technologies, Inc. Corporation Information
11.9.2 Agilent Technologies, Inc. Business Overview
11.9.3 Agilent Technologies, Inc. Multiomics Product Features and Attributes
11.9.4 Agilent Technologies, Inc. Multiomics Revenue and Gross Margin (2020-2025)
11.9.5 Agilent Technologies, Inc. Recent Developments
11.10 BGI Genomics
11.10.1 BGI Genomics Corporation Information
11.10.2 BGI Genomics Business Overview
11.10.3 BGI Genomics Multiomics Product Features and Attributes
11.10.4 BGI Genomics Multiomics Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
12 MultiomicsIndustry Chain Analysis
12.1 Multiomics Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Multiomics Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Multiomics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
BD
Thermo Fisher Scientific Inc
Illumina Inc
Danaher (Beckman Coulter)
PerkinElmer Inc
Shimadzu Corporation
Bruker
Qiagen NV
Agilent Technologies Inc
BGI Genomics
List of Tables
 Table 1. Global Multiomics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Multiomics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Multiomics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Multiomics Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Multiomics Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Multiomics Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Multiomics Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Multiomics by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiomics as of 2024)
 Table 11. Global Multiomics Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Multiomics Companies Headquarters
 Table 13. Global Multiomics Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Multiomics Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Multiomics Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Multiomics Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Multiomics Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Multiomics High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Multiomics Growth Accelerators and Market Barriers
 Table 25. North America Multiomics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Multiomics Growth Accelerators and Market Barriers
 Table 27. Europe Multiomics Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Multiomics Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Multiomics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Multiomics Investment Opportunities and Key Challenges
 Table 31. Central and South America Multiomics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Multiomics Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Multiomics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. BD Corporation Information
 Table 35. BD Description and Major Businesses
 Table 36. BD Product Features and Attributes
 Table 37. BD Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. BD Revenue Proportion by Product in 2024
 Table 39. BD Revenue Proportion by Application in 2024
 Table 40. BD Revenue Proportion by Geographic Area in 2024
 Table 41. BD Multiomics SWOT Analysis
 Table 42. BD Recent Developments
 Table 43. Thermo Fisher Scientific, Inc. Corporation Information
 Table 44. Thermo Fisher Scientific, Inc. Description and Major Businesses
 Table 45. Thermo Fisher Scientific, Inc. Product Features and Attributes
 Table 46. Thermo Fisher Scientific, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Thermo Fisher Scientific, Inc. Revenue Proportion by Product in 2024
 Table 48. Thermo Fisher Scientific, Inc. Revenue Proportion by Application in 2024
 Table 49. Thermo Fisher Scientific, Inc. Revenue Proportion by Geographic Area in 2024
 Table 50. Thermo Fisher Scientific, Inc. Multiomics SWOT Analysis
 Table 51. Thermo Fisher Scientific, Inc. Recent Developments
 Table 52. Illumina, Inc Corporation Information
 Table 53. Illumina, Inc Description and Major Businesses
 Table 54. Illumina, Inc Product Features and Attributes
 Table 55. Illumina, Inc Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Illumina, Inc Revenue Proportion by Product in 2024
 Table 57. Illumina, Inc Revenue Proportion by Application in 2024
 Table 58. Illumina, Inc Revenue Proportion by Geographic Area in 2024
 Table 59. Illumina, Inc Multiomics SWOT Analysis
 Table 60. Illumina, Inc Recent Developments
 Table 61. Danaher (Beckman Coulter) Corporation Information
 Table 62. Danaher (Beckman Coulter) Description and Major Businesses
 Table 63. Danaher (Beckman Coulter) Product Features and Attributes
 Table 64. Danaher (Beckman Coulter) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Danaher (Beckman Coulter) Revenue Proportion by Product in 2024
 Table 66. Danaher (Beckman Coulter) Revenue Proportion by Application in 2024
 Table 67. Danaher (Beckman Coulter) Revenue Proportion by Geographic Area in 2024
 Table 68. Danaher (Beckman Coulter) Multiomics SWOT Analysis
 Table 69. Danaher (Beckman Coulter) Recent Developments
 Table 70. PerkinElmer, Inc Corporation Information
 Table 71. PerkinElmer, Inc Description and Major Businesses
 Table 72. PerkinElmer, Inc Product Features and Attributes
 Table 73. PerkinElmer, Inc Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. PerkinElmer, Inc Revenue Proportion by Product in 2024
 Table 75. PerkinElmer, Inc Revenue Proportion by Application in 2024
 Table 76. PerkinElmer, Inc Revenue Proportion by Geographic Area in 2024
 Table 77. PerkinElmer, Inc Multiomics SWOT Analysis
 Table 78. PerkinElmer, Inc Recent Developments
 Table 79. Shimadzu Corporation Corporation Information
 Table 80. Shimadzu Corporation Description and Major Businesses
 Table 81. Shimadzu Corporation Product Features and Attributes
 Table 82. Shimadzu Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Shimadzu Corporation Recent Developments
 Table 84. Bruker Corporation Information
 Table 85. Bruker Description and Major Businesses
 Table 86. Bruker Product Features and Attributes
 Table 87. Bruker Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Bruker Recent Developments
 Table 89. QIAGEN Corporation Information
 Table 90. QIAGEN Description and Major Businesses
 Table 91. QIAGEN Product Features and Attributes
 Table 92. QIAGEN Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. QIAGEN Recent Developments
 Table 94. Agilent Technologies, Inc. Corporation Information
 Table 95. Agilent Technologies, Inc. Description and Major Businesses
 Table 96. Agilent Technologies, Inc. Product Features and Attributes
 Table 97. Agilent Technologies, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Agilent Technologies, Inc. Recent Developments
 Table 99. BGI Genomics Corporation Information
 Table 100. BGI Genomics Description and Major Businesses
 Table 101. BGI Genomics Product Features and Attributes
 Table 102. BGI Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. BGI Genomics Recent Developments
 Table 104. Raw Materials Key Suppliers
 Table 105. Distributors List
 Table 106. Market Trends and Market Evolution
 Table 107. Market Drivers and Opportunities
 Table 108. Market Challenges, Risks, and Restraints
 Table 109. Research Programs/Design for This Report
 Table 110. Key Data Information from Secondary Sources
 Table 111. Key Data Information from Primary Sources


List of Figures
 Figure 1. Multiomics Product Picture
 Figure 2. Global Multiomics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Single-cell Multiomics Product Picture
 Figure 4. Bulk Multiomics Product Picture
 Figure 5. Global Multiomics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Cell Biology
 Figure 7. Oncology
 Figure 8. Neurology
 Figure 9. Immunology
 Figure 10. Others
 Figure 11. Multiomics Report Years Considered
 Figure 12. Global Multiomics Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Multiomics Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Multiomics Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Multiomics Revenue Market Share by Region (2020-2031)
 Figure 16. Global Multiomics Revenue Market Share Ranking (2024)
 Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 18. Single-cell Multiomics Revenue Market Share by Player in 2024
 Figure 19. Bulk Multiomics Revenue Market Share by Player in 2024
 Figure 20. Global Multiomics Revenue Market Share by Type (2020-2031)
 Figure 21. Global Multiomics Revenue Market Share by Application (2020-2031)
 Figure 22. North America Multiomics Revenue YoY (2020-2031) & (US$ Million)
 Figure 23. North America Top 5 Players Multiomics Revenue (US$ Million) in 2024
 Figure 24. North America Multiomics Revenue (US$ Million) by Type (2020 - 2031)
 Figure 25. North America Multiomics Revenue (US$ Million) by Application (2020-2031)
 Figure 26. US Multiomics Revenue (2020-2031) & (US$ Million)
 Figure 27. Canada Multiomics Revenue (2020-2031) & (US$ Million)
 Figure 28. Mexico Multiomics Revenue (2020-2031) & (US$ Million)
 Figure 29. Europe Multiomics Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. Europe Top 5 Players Multiomics Revenue (US$ Million) in 2024
 Figure 31. Europe Multiomics Revenue (US$ Million) by Type (2020-2031)
 Figure 32. Europe Multiomics Revenue (US$ Million) by Application (2020-2031)
 Figure 33. Germany Multiomics Revenue (2020-2031) & (US$ Million)
 Figure 34. France Multiomics Revenue (2020-2031) & (US$ Million)
 Figure 35. U.K. Multiomics Revenue (2020-2031) & (US$ Million)
 Figure 36. Italy Multiomics Revenue (2020-2031) & (US$ Million)
 Figure 37. Russia Multiomics Revenue (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Multiomics Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific Top 8 Players Multiomics Revenue (US$ Million) in 2024
 Figure 40. Asia-Pacific Multiomics Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Asia-Pacific Multiomics Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Indonesia Multiomics Revenue (2020-2031) & (US$ Million)
 Figure 43. Japan Multiomics Revenue (2020-2031) & (US$ Million)
 Figure 44. South Korea Multiomics Revenue (2020-2031) & (US$ Million)
 Figure 45. Australia Multiomics Revenue (2020-2031) & (US$ Million)
 Figure 46. India Multiomics Revenue (2020-2031) & (US$ Million)
 Figure 47. Indonesia Multiomics Revenue (2020-2031) & (US$ Million)
 Figure 48. Vietnam Multiomics Revenue (2020-2031) & (US$ Million)
 Figure 49. Malaysia Multiomics Revenue (2020-2031) & (US$ Million)
 Figure 50. Philippines Multiomics Revenue (2020-2031) & (US$ Million)
 Figure 51. Singapore Multiomics Revenue (2020-2031) & (US$ Million)
 Figure 52. Central and South America Multiomics Revenue YoY (2020-2031) & (US$ Million)
 Figure 53. Central and South America Top 5 Players Multiomics Revenue (US$ Million) in 2024
 Figure 54. Central and South America Multiomics Revenue (US$ Million) by Type (2020-2031)
 Figure 55. Central and South America Multiomics Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Brazil Multiomics Revenue (2020-2025) & (US$ Million)
 Figure 57. Argentina Multiomics Revenue (2020-2025) & (US$ Million)
 Figure 58. Middle East and Africa Multiomics Revenue YoY (2020-2031) & (US$ Million)
 Figure 59. Middle East and Africa Top 5 Players Multiomics Revenue (US$ Million) in 2024
 Figure 60. South America Multiomics Revenue (US$ Million) by Type (2020-2031)
 Figure 61. Middle East and Africa Multiomics Revenue (US$ Million) by Application (2020-2031)
 Figure 62. GCC Countries Multiomics Revenue (2020-2025) & (US$ Million)
 Figure 63. Israel Multiomics Revenue (2020-2025) & (US$ Million)
 Figure 64. Egypt Multiomics Revenue (2020-2025) & (US$ Million)
 Figure 65. South Africa Multiomics Revenue (2020-2025) & (US$ Million)
 Figure 66. Multiomics Industry Chain Mapping
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Omics Based Clinical Trials Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Single Cell Multi Omics Market Research Report 2024
Single Cell Multiomics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Spatial Multi Omics Solution Market Research Report 2024
Global Metagenomics in Healthcare Market Research Report 2024
Global Metagenomics Kits Market Research Report 2024
Global Microbiome Sample Preparation Technology Market Research Report 2024
Metagenomics Next Generation Sequencing Market
Metabolomics Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Genomics Software Market Research Report 2024
Global Metabolomics Mixes and Kits Market Research Report 2024
Global Epigenome Analysis Market Research Report 2025
Global Spatial Omics Market Research Report 2024
Global Agricultural Genome Market Insights Forecast to 2030
Global Whole Transcriptomics Sequencing Market Insights Forecast to 2030
Global Microbial Mass Spectrometry Market Insights Forecast to 2030
Global Spatial Metabolomics Market Research Report 2024
Global Methylation Analysis Market Research Report 2025
Global Next Generation Sequencing Informatics Market Size Status and Forecast 2020 2026
Global Genomics Solutions Market Research Report 2024

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions